The selling down of any companies that do not make free cash flow has been universal and relentless. Those that have more immediate prospects of cash flows less so, those that do not, hammered on capital/credit fears.
It was only two years ago on Reddit or the like that you'd jump on and retail investors telling you this time was different: YOLO - your once in a lifetime opportunity. Yes your YOLO of buying the temporary highs in debt/economic cycles that have played out for years and will yet again in the future.
Business goes on, despite the cycle, sometimes hampered, sometimes thriving. Osteopore has some green shoots of rapidly growing existing sales on a large global sales footprint (arguably too large and too expensive outlay - running before it could walk). It is just entering the US mkt and has the promise of some future Chinese sales and hopefully more immediate capital injection via a partnership emerging from the Temasek linked deal. Its sad that prospects of such companies are so binary now.
The future of OSX is very much up in the air, but these are the opportunities for excellent entry prices, not without considerable risk to your investment of course. You have to wonder, looking at the trading levels and volume in its history since IPO, why investors would consider it a buy at $0.40+ (volumes suggesting that where a massive amount of investors bought in) and now a sell at $0.052, given, the admittedly very disappointingly business progress, but undeniably progress, the company has made.
If OSX gets some capital from Singapore/China (I wouldn't mind if they even took on new debt here) and manages to continue its growth and this is the bottom of the debt cycle (I personally think it is but only a shallow recovery contrary to money markets, due to entrenched inflationary pressures) then buyers may prove to get an absolute bargain here - sorry stating the obvious. Its a patient wait to the next qtrly sales figures or a capital injection of some form for me.
- Forums
- ASX - By Stock
- OSX
- Ann: MOU with Temasek-linked Innoventures - Orthopaedics in China
Ann: MOU with Temasek-linked Innoventures - Orthopaedics in China, page-29
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSX (ASX) to my watchlist
|
|||||
Last
4.0¢ |
Change
-0.001(1.25%) |
Mkt cap ! $4.564M |
Open | High | Low | Value | Volume |
4.0¢ | 4.0¢ | 3.8¢ | $53.01K | 1.377M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 20636 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 20636 | 0.039 |
4 | 185439 | 0.038 |
4 | 319080 | 0.037 |
4 | 205552 | 0.036 |
2 | 114281 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 20000 | 1 |
0.041 | 621 | 1 |
0.042 | 71352 | 2 |
0.043 | 74483 | 2 |
0.044 | 512903 | 2 |
Last trade - 15.52pm 05/09/2024 (20 minute delay) ? |
Featured News
OSX (ASX) Chart |